125 related articles for article (PubMed ID: 31711342)
21. Associations between quantitative [
Timmers T; Ossenkoppele R; Wolters EE; Verfaillie SCJ; Visser D; Golla SSV; Barkhof F; Scheltens P; Boellaard R; van der Flier WM; van Berckel BNM
Alzheimers Res Ther; 2019 Jul; 11(1):60. PubMed ID: 31272512
[TBL] [Abstract][Full Text] [Related]
22. Quantitative
Zhao Q; Liu M; Ha L; Zhou Y;
Front Neurol; 2019; 10():486. PubMed ID: 31156534
[TBL] [Abstract][Full Text] [Related]
23. [F-18]-AV-1451 binding correlates with postmortem neurofibrillary tangle Braak staging.
Marquié M; Siao Tick Chong M; Antón-Fernández A; Verwer EE; Sáez-Calveras N; Meltzer AC; Ramanan P; Amaral AC; Gonzalez J; Normandin MD; Frosch MP; Gómez-Isla T
Acta Neuropathol; 2017 Oct; 134(4):619-628. PubMed ID: 28612291
[TBL] [Abstract][Full Text] [Related]
24. Non-invasive assessment of Alzheimer's disease neurofibrillary pathology using 18F-THK5105 PET.
Okamura N; Furumoto S; Fodero-Tavoletti MT; Mulligan RS; Harada R; Yates P; Pejoska S; Kudo Y; Masters CL; Yanai K; Rowe CC; Villemagne VL
Brain; 2014 Jun; 137(Pt 6):1762-71. PubMed ID: 24681664
[TBL] [Abstract][Full Text] [Related]
25. Dynamic PET Measures of Tau Accumulation in Cognitively Normal Older Adults and Alzheimer's Disease Patients Measured Using [18F] THK-5351.
Lockhart SN; Baker SL; Okamura N; Furukawa K; Ishiki A; Furumoto S; Tashiro M; Yanai K; Arai H; Kudo Y; Harada R; Tomita N; Hiraoka K; Watanuki S; Jagust WJ
PLoS One; 2016; 11(6):e0158460. PubMed ID: 27355840
[TBL] [Abstract][Full Text] [Related]
26. Voxel-based analysis of Alzheimer's disease PET imaging using a triplet of radiotracers: PIB, FDDNP, and FDG.
Shin J; Lee SY; Kim SJ; Kim SH; Cho SJ; Kim YB
Neuroimage; 2010 Aug; 52(2):488-96. PubMed ID: 20385246
[TBL] [Abstract][Full Text] [Related]
27. Quantification of 18F-JNJ-42259152, a novel phosphodiesterase 10A PET tracer: kinetic modeling and test-retest study in human brain.
Van Laere K; Ahmad RU; Hudyana H; Dubois K; Schmidt ME; Celen S; Bormans G; Koole M
J Nucl Med; 2013 Aug; 54(8):1285-93. PubMed ID: 23843566
[TBL] [Abstract][Full Text] [Related]
28. Tau positron emission tomography using [
Kang JM; Lee SY; Seo S; Jeong HJ; Woo SH; Lee H; Lee YB; Yeon BK; Shin DH; Park KH; Kang H; Okamura N; Furumoto S; Yanai K; Villemagne VL; Seong JK; Na DL; Ido T; Cho J; Lee KM; Noh Y
Neurobiol Aging; 2017 Nov; 59():210-219. PubMed ID: 28890300
[TBL] [Abstract][Full Text] [Related]
29. Repeatability of parametric methods for [
Verfaillie SC; Golla SS; Timmers T; Tuncel H; van der Weijden CW; Schober P; Schuit RC; van der Flier WM; Windhorst AD; Lammertsma AA; van Berckel BN; Boellaard R
J Cereb Blood Flow Metab; 2021 Mar; 41(3):569-578. PubMed ID: 32321347
[TBL] [Abstract][Full Text] [Related]
30. Characterization of 3 Novel Tau Radiopharmaceuticals,
Wong DF; Comley RA; Kuwabara H; Rosenberg PB; Resnick SM; Ostrowitzki S; Vozzi C; Boess F; Oh E; Lyketsos CG; Honer M; Gobbi L; Klein G; George N; Gapasin L; Kitzmiller K; Roberts J; Sevigny J; Nandi A; Brasic J; Mishra C; Thambisetty M; Mogekar A; Mathur A; Albert M; Dannals RF; Borroni E
J Nucl Med; 2018 Dec; 59(12):1869-1876. PubMed ID: 29728519
[No Abstract] [Full Text] [Related]
31. Simplified quantification of Pittsburgh Compound B amyloid imaging PET studies: a comparative analysis.
Lopresti BJ; Klunk WE; Mathis CA; Hoge JA; Ziolko SK; Lu X; Meltzer CC; Schimmel K; Tsopelas ND; DeKosky ST; Price JC
J Nucl Med; 2005 Dec; 46(12):1959-72. PubMed ID: 16330558
[TBL] [Abstract][Full Text] [Related]
32. Autoradiography validation of novel tau PET tracer [F-18]-MK-6240 on human postmortem brain tissue.
Aguero C; Dhaynaut M; Normandin MD; Amaral AC; Guehl NJ; Neelamegam R; Marquie M; Johnson KA; El Fakhri G; Frosch MP; Gomez-Isla T
Acta Neuropathol Commun; 2019 Mar; 7(1):37. PubMed ID: 30857558
[TBL] [Abstract][Full Text] [Related]
33. PET of brain amyloid and tau in mild cognitive impairment.
Small GW; Kepe V; Ercoli LM; Siddarth P; Bookheimer SY; Miller KJ; Lavretsky H; Burggren AC; Cole GM; Vinters HV; Thompson PM; Huang SC; Satyamurthy N; Phelps ME; Barrio JR
N Engl J Med; 2006 Dec; 355(25):2652-63. PubMed ID: 17182990
[TBL] [Abstract][Full Text] [Related]
34. Validation of the Semiquantitative Static SUVR Method for
Ottoy J; Verhaeghe J; Niemantsverdriet E; Wyffels L; Somers C; De Roeck E; Struyfs H; Soetewey F; Deleye S; Van den Bossche T; Van Mossevelde S; Ceyssens S; Versijpt J; Stroobants S; Engelborghs S; Staelens S
J Nucl Med; 2017 Sep; 58(9):1483-1489. PubMed ID: 28336779
[TBL] [Abstract][Full Text] [Related]
35. Discovery of 6-(Fluoro-(18)F)-3-(1H-pyrrolo[2,3-c]pyridin-1-yl)isoquinolin-5-amine ([(18)F]-MK-6240): A Positron Emission Tomography (PET) Imaging Agent for Quantification of Neurofibrillary Tangles (NFTs).
Walji AM; Hostetler ED; Selnick H; Zeng Z; Miller P; Bennacef I; Salinas C; Connolly B; Gantert L; Holahan M; O'Malley S; Purcell M; Riffel K; Li J; Balsells J; OBrien JA; Melquist S; Soriano A; Zhang X; Ogawa A; Xu S; Joshi E; Della Rocca J; Hess FJ; Schachter J; Hesk D; Schenk D; Struyk A; Babaoglu K; Lohith TG; Wang Y; Yang K; Fu J; Evelhoch JL; Coleman PJ
J Med Chem; 2016 May; 59(10):4778-89. PubMed ID: 27088900
[TBL] [Abstract][Full Text] [Related]
36. In Vivo Detection of Neurofibrillary Tangles by
Michiels L; Thijs L; Mertens N; Sunaert S; Vandenbulcke M; Bormans G; Verheyden G; Koole M; Van Laere K; Lemmens R
Neurology; 2023 Jan; 100(1):e62-e71. PubMed ID: 36302665
[TBL] [Abstract][Full Text] [Related]
37. Characterization of the novel GlyT1 PET tracer [18F]MK-6577 in humans.
Joshi AD; Sanabria-Bohórquez SM; Bormans G; Koole M; De Hoon J; Van Hecken A; Depre M; De Lepeleire I; Van Laere K; Sur C; Hamill TG
Synapse; 2015 Jan; 69(1):33-40. PubMed ID: 25196464
[TBL] [Abstract][Full Text] [Related]
38. Regional profiles of the candidate tau PET ligand 18F-AV-1451 recapitulate key features of Braak histopathological stages.
Schwarz AJ; Yu P; Miller BB; Shcherbinin S; Dickson J; Navitsky M; Joshi AD; Devous MD; Mintun MS
Brain; 2016 May; 139(Pt 5):1539-50. PubMed ID: 26936940
[TBL] [Abstract][Full Text] [Related]
39. A Visual Interpretation Algorithm for Assessing Brain Tauopathy with
Seibyl JP; DuBois JM; Racine A; Collins J; Guo Q; Wooten D; Stage E; Cheng D; Gunn RN; Porat L; Whittington A; Kuo PH; Ichise M; Comley R; Martarello L; Salinas C
J Nucl Med; 2023 Mar; 64(3):444-451. PubMed ID: 36175137
[TBL] [Abstract][Full Text] [Related]
40. First-in-Human Assessment of the Novel PDE2A PET Radiotracer 18F-PF-05270430.
Naganawa M; Waterhouse RN; Nabulsi N; Lin SF; Labaree D; Ropchan J; Tarabar S; DeMartinis N; Ogden A; Banerjee A; Huang Y; Carson RE
J Nucl Med; 2016 Sep; 57(9):1388-95. PubMed ID: 27103022
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
